You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Insulin Growth Factor-1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Drug Effect Trial in Tanta (Cinacalcet)

Recruiting
  • Drug Effect
  • Tanta, Egypt
    Sara Mabrouk Mohamed Elghoul
Jun 29, 2023

Insulin Like Growth Factor-1 Against Oxidative Stress in

Not yet recruiting
  • Vitiligo
  • skin biopsy examined by ELISA technique
  • (no location specified)
Apr 13, 2023

UVB Phototherapy Burn, Insulin-like Growth Factor 1, Aging Trial in Fairborn (Insulin-Like Growth Factor 1, No Insulin-Lie

Recruiting
  • UVB Phototherapy Burn
  • +2 more
  • Insulin-Like Growth Factor 1
  • No Insulin-Lie Growth Factor 1
  • Fairborn, Ohio
    Wright State Physicians
Jan 9, 2023

Pre-frail Elderly Trial in Jakarta (Cholecalciferol, Placebo)

Completed
  • Pre-frail Elderly
  • Jakarta, DKI Jakarta, Indonesia
    Cipto Mangunkusumo General Hospital
Jan 25, 2023

Acute Kidney Injury (Nontraumatic), Pneumoperitoneum Trial (IGF-1)

Not yet recruiting
  • Acute Kidney Injury (Nontraumatic)
  • Pneumoperitoneum
  • IGF-1
  • (no location specified)
Nov 8, 2022

Relation Between Serum IGF-1 & BMI In Acne Vulgaris

Not yet recruiting
  • Evaluation of Serum Level of Insulin Like Growth Factor 1
    • (no location specified)
    Aug 16, 2022

    Growth Hormone in EB

    Not yet recruiting
    • Epidermolysis Bullosa Dystrophica
    • growth hormone level and insulin like growth factor 1
    • (no location specified)
    May 24, 2022

    Cancer, Overweight and Obesity Trial (Aerobic Exercise)

    Not yet recruiting
    • Cancer
    • Overweight and Obesity
    • Aerobic Exercise
    • (no location specified)
    Dec 13, 2022

    Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal Trial in Los Angeles, Bethesda (Dasatinib, Ganitumab)

    Terminated
    Has Results
    • Rhabdomyosarcoma
    • +2 more
    • Los Angeles, California
    • +1 more
    Mar 17, 2022

    Short Stature Trial (Increlex)

    Active, not recruiting
    • Short Stature
    • (no location specified)
    Oct 14, 2022

    22q13 Deletion Syndrome, Phelan-McDermid Syndrome Trial in New York (Insulin-Like Growth Factor-1 (IGF-1), Normal saline)

    Completed
    Has Results
    • 22q13 Deletion Syndrome
    • Phelan-McDermid Syndrome
    • Insulin-Like Growth Factor-1 (IGF-1)
    • Normal saline
    • New York, New York
      Seaver Austin Center, Icahn School of Medicine at Mount Sinai
    Apr 18, 2022

    Anorexia Nervosa Trial in Boston (RhIGF-1)

    Completed
    Has Results
    • Anorexia Nervosa
    • Boston, Massachusetts
      Massachusetts General Hospital
    Oct 22, 2021

    Disorder of Bone Density and Structure, Unspecified Trial in Boston (Recombinant human insulin like growth factor-1 (rhIGF-1))

    Completed
    Has Results
    • Disorder of Bone Density and Structure, Unspecified
    • Recombinant human insulin like growth factor-1 (rhIGF-1)
    • Boston, Massachusetts
      Massachusetts General Hospital
    Oct 22, 2021

    Health Status of Children Born After Assisted Reproductive

    Recruiting
    • Children Born After Assisted Reproductive Technologies
    • +2 more
    • hemogram examination
    • Almaty, Kazakhstan
      Sevara ilmuratova
    Oct 17, 2023

    Insulin Growth Factor I Deficiency, IGF1 Deficiency, Executive Function Disorder Trial in Seville (HIIT, HIIT+PA, CON)

    Recruiting
    • Insulin Growth Factor I Deficiency
    • +2 more
    • HIIT
    • +2 more
    • Seville, Spain
      Education Faculty
    Nov 30, 2022

    Acne Vulgaris Trial (Topical Metformin Emulgel and salicylic acid, Insulin- Like growth factor (ILGF-1))

    Not yet recruiting
    • Acne Vulgaris
    • Topical Metformin Emulgel and salicylic acid
    • Insulin- Like growth factor (ILGF-1)
    • (no location specified)
    Sep 7, 2022

    Myotonic Dystrophy Type 1 Trial in United States (rhIGF-I/rhIGFBP-3, )

    Completed
    Has Results
    • Myotonic Dystrophy Type 1
    • Orange, California
    • +11 more
    Dec 8, 2021

    Serum Insulin-like Growth Factor Binding Protein-3 asPotential

    Not yet recruiting
    • Colorectal Cancer
    • evaluation of diagnostic importance of insulin like growth factor binding protein3 in patient with recently diagnosed as Colorectal cancer
    • (no location specified)
    May 6, 2023

    Ataxia, Spinocerebellar, Insulin-Like Growth Factor I, Medicine, Chinese Traditional Trial in Changhua (Chinese medicine WT)

    Recruiting
    • Ataxia, Spinocerebellar
    • +2 more
    • Chinese medicine WT
    • Changhua, Taiwan
      Changhua Christian Hospital
    Oct 22, 2021

    IGF1 Deficiency Trial in Worldwide (Increlex®)

    Recruiting
    • IGF1 Deficiency
    • Miami, Florida
    • +50 more
    Dec 29, 2022

    AR, IGF-IR, IR and Peripheral Artery Disease

    Recruiting
    • Androgen Receptor Abnormal
    • +2 more
    • arterial reconstructive open surgery
    • Catanzaro, Italy
      University Magna Graecia of Catanzaro
    Jan 12, 2021

    Insulin-Like Growth Factor-1 Deficiency, Growth Disorders Trial in Brisbane (rhIGF-1 (mecasermin) for a period of 86 weeks)

    Completed
    Has Results
    • Insulin-Like Growth Factor-1 Deficiency
    • Growth Disorders
    • rhIGF-1 (mecasermin) for a period of 86 weeks
    • Brisbane, California
      Ipsen
    Jul 7, 2020

    Prostate Cancer Trial in Oxford (Xentuzumab)

    Recruiting
    • Prostate Cancer
    • Oxford, United Kingdom
      Churchill Hospital, Oxford University Hospitals
    Mar 14, 2022

    Tendinopathy, Patellar Ligament, Platelet-Rich Plasma Trial in Columbus (Platelet Rich Plasma, Platelet Rich Plasma plus IGF)

    Completed
    • Tendinopathy
    • +2 more
    • Platelet Rich Plasma
    • Platelet Rich Plasma plus IGF
    • Columbus, Ohio
      The Ohio State University Sports Medicine Center
    Aug 4, 2022

    Growth Disorders Trial in Paris (rh IGF-1 (mecasermin))

    Terminated
    Has Results
    • Growth Disorders
    • rh IGF-1 (mecasermin)
    • Paris, France
      Ipsen
    Aug 5, 2020